Compare DRUG & MSBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DRUG | MSBI |
|---|---|---|
| Founded | 2019 | 1881 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 364.8M | 315.4M |
| IPO Year | N/A | 2016 |
| Metric | DRUG | MSBI |
|---|---|---|
| Price | $83.06 | $21.52 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 3 |
| Target Price | ★ $83.00 | $19.67 |
| AVG Volume (30 Days) | 159.4K | ★ 242.4K |
| Earning Date | 12-29-2025 | 01-22-2026 |
| Dividend Yield | N/A | ★ 5.93% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $210,718,000.00 |
| Revenue This Year | N/A | $28.11 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $23.18 | $14.24 |
| 52 Week High | $97.75 | $25.76 |
| Indicator | DRUG | MSBI |
|---|---|---|
| Relative Strength Index (RSI) | 58.35 | 76.57 |
| Support Level | $77.80 | $21.07 |
| Resistance Level | $97.75 | $22.29 |
| Average True Range (ATR) | 8.78 | 0.75 |
| MACD | 0.06 | 0.21 |
| Stochastic Oscillator | 48.68 | 86.13 |
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
Midland States Bancorp Inc is a diversified financial holding company. The company provides a full range of commercial and consumer banking products and services, business equipment financing, merchant credit card services, trust and investment management, and insurance and financial planning services. The Banking segment, which generates the majority of the revenue, provides financial products and services to consumers and businesses, including commercial, commercial real estate, mortgage, and other consumer loan products; commercial equipment financing, etc. The Wealth Management segment consists of trust and fiduciary services, brokerage, and retirement planning services. The Corporate segment includes the holding company's financing and investment activities, administrative expenses.